Literature DB >> 16996910

Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?

Heyman Luckraz1, Martin Goddard, Keith McNeil, Carl Atkinson, Linda D Sharples, John Wallwork.   

Abstract

BACKGROUND: Acute rejection, a vascular-based disorder, has been identified as the major risk factor for obliterative bronchiolitis (OB), an airway-based pathology. This study investigated the hypothesis that changes to the microvascular blood supply of small airways were associated with the development of OB, thus providing a possible link between an acute vascular insult (acute rejection) and chronic airway changes (OB).
METHODS: Microvasculature of 695 small airways (99 patients) was assessed in post-mortem lung allograft specimens using monoclonal antibodies for von Willebrand factor and CD31. Group A consisted of 343 small airways from 58 patients with no evidence of OB. The remaining 41 patients had histological evidence of OB in some of their small airways and grouped as B, C, and D with some patients contributing to all three groups ie, their lung specimen had some small airways which were completely obliterated with OB, some airways which were partially obliterated and some small airways without any histological evidence of OB development. Thus group B consisted of 145 small airways (34 patients) without OB. Group C consisted of 171 small airways with partial luminal obstruction (36 patients). Group D consisted of 36 small airways (14 patients) with complete luminal obliteration.
RESULTS: Airway circumference (mean +/- standard deviation) was 2.36 +/- 0.37, 2.41 +/- 0.51, 2.49 +/- 0.51, and 2.57 +/- 0.79 mm, respectively (p = 0.40). Mean number of blood vessels per unit length of airway circumference was 4.12 +/- 1.1, 1.58 +/- 0.61, 2.42 +/- 1.06, and 4.42 +/- 1.46 vessels/mm, respectively (p < 0.001). Blood vessels with circumference greater than 0.2 mm were present in 100%, 64%, 39%, and 7% of small airways, respectively (p < 0.001). Univariate and multivariate analyses (donor and recipient age, sex, and cytomegalovirus status, recipient pretransplant diagnosis, ischemic times, acute rejection and infective episodes, postoperative survival days, recipient group [A to D], blood vessels per unit length, and airway circumference) confirmed that reduction in blood vessels per unit length was associated with the development of OB and was time-independent.
CONCLUSIONS: Obliterative bronchiolitis was preceded by a decrease in microvascular supply to the small airways (group B). The subsequent onset of airway scarring (groups C and D) was associated with an increased number of significantly smaller vessels, suggestive of neovascularization.

Entities:  

Mesh:

Year:  2006        PMID: 16996910     DOI: 10.1016/j.athoracsur.2006.03.070

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

1.  Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Authors:  X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls
Journal:  Am J Transplant       Date:  2015-02-27       Impact factor: 8.086

2.  Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.

Authors:  Ashok N Babu; Tomohiro Murakawa; Joshua M Thurman; Edmund J Miller; Peter M Henson; Martin R Zamora; Norbert F Voelkel; Mark R Nicolls
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 3.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

4.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

5.  Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.

Authors:  Bryan D Kraft; Hagir B Suliman; Eli C Colman; Kamran Mahmood; Matthew G Hartwig; Claude A Piantadosi; Scott L Shofer
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

6.  A Critical Role for Airway Microvessels in Lung Transplantation.

Authors:  Mark R Nicolls; Gundeep S Dhillon; Niccolò Daddi
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

7.  Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1.

Authors:  Rebecca Liu; Jonathan Merola; Thomas D Manes; Lingfeng Qin; Gregory T Tietjen; Francesc López-Giráldez; Verena Broecker; Caodi Fang; Catherine Xie; Ping-Min Chen; Nancy C Kirkiles-Smith; Dan Jane-Wit; Jordan S Pober
Journal:  JCI Insight       Date:  2018-03-08

Review 8.  Bronchial blood supply after lung transplantation without bronchial artery revascularization.

Authors:  Mark R Nicolls; Martin R Zamora
Journal:  Curr Opin Organ Transplant       Date:  2010-10       Impact factor: 2.640

9.  Targeting complement component 5a promotes vascular integrity and limits airway remodeling.

Authors:  Mohammad A Khan; Christian Maasch; Axel Vater; Sven Klussmann; John Morser; Lawrence L Leung; Carl Atkinson; Stephen Tomlinson; Peter S Heeger; Mark R Nicolls
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

10.  Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis.

Authors:  Annika Andersson-Sjöland; Jonas S Erjefält; Leif Bjermer; Leif Eriksson; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2009-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.